K-numberK242368
Device nameSymani Surgical System
ApplicantMedical Microinstruments, Inc.
Product codeSAQ
Device classClass II
Decision dateFeb 7, 2025
DecisionSubstantially Equivalent
Regulation878.4963
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Symani Surgical System is an electromechanical robotic-assisted device designed to assist microsurgeons in performing precise vascular anastomosis, suturing, and ligation on small blood vessels and lymphatic ducts (0.1-2.5 mm diameter) during free-flap reconstruction surgery in the breast, mouth, scalp, extremities, and lymphatic surgery. The system provides motion scaling (7x to 20x magnification) to reduce surgeon tremor and improve dexterity, intended for use by trained physicians in adults.

Technological characteristics

The Symani Surgical System has identical technological characteristics to its predicate device (DEN230032). It consists of three components: a CMM (control motion module), Console, and Instruments with wristed end-effectors. This 510(k) submission represents a labeling modification only, adding mouth and scalp indications to the existing open free-flap surgery indication; no design or technological changes were made.

Test standards cited

Not stated in this summary.

Substantial equivalence argument

Substantial equivalence is established because: (1) the subject device has identical intended use and technological characteristics as the predicate device; (2) clinical data from 62 patients (55 prospective, 7 retrospective) undergoing mouth and scalp free-flap procedures demonstrated safety and effectiveness comparable to the predicate, with 90.9% patency at first attempt for mouth procedures and 100% final patency for all anastomoses; and (3) zero serious adverse device effects occurred, with adverse event rates consistent with published literature for head/neck procedures. The lower scalp first-attempt patency (69.2%) is attributable to unique anatomical challenges, but final patency confirmation prior to closure mitigates this difference.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →